An aqueous pharmaceutical suspension comprising: (i) at least one non-steroidal anti-inflammatory drug； (ii) an aqueous buffer system； (iii) xanthan gum； (iv) polyvinyl pyrrolidone； and (v) glycerol wherein the suspension is free from pregelatinised starch, amino polycarboxylic acid, microcrystalline cellulose, hydroxypropylmethyl cellulose, polyoxyethylene sorbitan monooleate, silicon dioxide and taste modifying agents selected from the group consisting of bulk sweeteners, intense sweeteners, flavouring agents and mixtures thereof.
